Yamaguchi, Ou
Kaira, Kyoichi
Naruse, Ichiro
Umeda, Yukihiro
Honda, Takeshi
Watanabe, Satoshi
Ichikawa, Kosuke
Tateishi, Kazunari
Kasahara, Norimitsu
Higuchi, Tetsuya
Hashimoto, Kosuke
Shinomiya, Shun
Miura, Yu
Shiono, Ayako
Mouri, Atsuto
Imai, Hisao
Iizuka, Kunihiko
Ishizuka, Tamotsu
Minato, Koichi
Suda, Satoshi
Kagamu, Hiroshi
Mori, Keita
Kuji, Ichiei
Seki, Nobuhiko
Funding for this research was provided by:
Nihon Medi-Physics Co.,Ltd.
Article History
Received: 26 March 2022
Accepted: 1 July 2022
First Online: 12 July 2022
Competing interests
: KK has received research grants and a speaker honorarium from Ono Pharmaceutical Company, Boehringer Ingelheim, Chugai Pharmaceutical, Taiho Pharmaceutical, Eli Lilly Japan, Nihon Medi-Physics Co.,Ltd and AstraZeneca. OY have received a speaker honorarium from Eli Lilly, Taiho Pharmaceutical, Pfizer, Chugai Pharmaceutical, and AstraZeneca. AM have received a speaker honorarium from Ono Pharmaceutical Company, Taiho Pharmaceutical, Pfizer, Daiichi Sankyo Company, Merck Biopharma Company, Novartis Pharma, Thermo Fisher Scientific, Chugai Pharmaceutical, and AstraZeneca. HK has received research grants and a speaker honorarium from Ono Pharmaceutical Company, Bristol-Myers Company, Boehringer Ingelheim, MSD, Daiichi Sankyo Company, Chugai Pharmaceutical, Taiho Pharmaceutical, Merck Biopharma Company, Eli Lilly Japan, and AstraZeneca. SW has received grants and a speaker honorarium from AstraZeneca, Eli Lilly and Boehringer Ingelheim, a speaker honorarium from Chugai Pharma, Ono Pharmaceutical, Bristol-Myers, MSD, Taiho Pharmaceutical, Pfizer, Novartis and Daiichi Sankyo. KI received research grants and a speaker honorarium from AstraZeneca, Chugai Pharma, Bristol-Myers, Boehringer Ingelheim, Ono Pharmaceutical, Taiho Pharmaceutical, Novartis International AG, Daiichi Sankyo Company. NS has received research grants and a speaker honorarium from Ono Pharmaceutical Company, Bristol-Myers Company, MSD, AstraZeneca, Chugai Pharmaceutical, Boehringer Ingelheim, Pfizer Japan, Eli Lilly Japan, Taiho Pharmaceutical, Daiichi Sankyo Company, and Merck Biopharma Company. IK has received research grants from FUJIFILM Toyama Chemical Co., Ltd. and Nihon Medi-Physics Co.,Ltd. All other authors declare no potential conflict of interest.